Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Consun Pharmaceutical Group Ltd. ( (HK:1681) ) has issued an announcement.
Consun Pharmaceutical Group Ltd. has proposed the adoption of a Share Award Scheme to incentivize and reward participants for the growth and development of the company. This scheme, which requires shareholder approval, aims to grant new shares under the Listing Rules, enhancing the company’s ability to motivate its workforce. The announcement also notes the expiration of the 2013 Share Option Scheme and the introduction of the 2024 Share Option Scheme, which has not yet granted any options but has set limits for future share allocations.
The most recent analyst rating on (HK:1681) stock is a Buy with a HK$17.00 price target. To see the full list of analyst forecasts on Consun Pharmaceutical Group Ltd. stock, see the HK:1681 Stock Forecast page.
More about Consun Pharmaceutical Group Ltd.
Average Trading Volume: 3,449,066
Technical Sentiment Signal: Buy
Current Market Cap: HK$12.33B
For detailed information about 1681 stock, go to TipRanks’ Stock Analysis page.